Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* documented HIV infection~* stable Protease Inhibitor containing HAART regimen for at least 12 months~* impaired glucose tolerance~* elevated insulin levels (above 20 mIU/l)~Exclusion Criteria:~* patients already taking oral hypoglycaemic treatment or insulin~* heart failure NYHA I-IV~* liver disease or kidney disease~* elevated AST or ALT above 2 times upper normal range~* elevated creatinine (above 150 mmol/l)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).